MEDICINES : PRICE TRANSPARENCY REQUIREMENTS: MEPS VOTE BUT END'S NOT NEAR.

• Position: Members of Parliament - Brief article

On 6 February, MEPs adopted a report by Antonyia Parvanova (ALDE, Bulgaria) on the transparency of medicine prices, in a context where "the financial viability of national health services is under pressure from the crisis, and the ageing of the population," according to the rapporteur.

The draft rules will require national authorities to meet new deadlines and transparency requirements on pricing and reimbursement. While the European Commission proposed in a draft directive, published in...